Legend Biotech Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | -127.0% | – | – | – | – | – | – | |
| – | +675.6% | +212.7% | +88.8% | +40.1% | +32.2% | +11.2% | +14.2% | +24.0% | |
| – | – | +80.7% | +274.2% | +323.5% | +70.3% | +38.9% | +44.6% | -6.3% | |
| – | -318.6% | – | – | +104.1% | -81.8% | – | – | – | |
| – | – | -83.5% | -144.3% | – | +11.9% | -139.4% | – | -565.9% | |
| – | +2,269.9% | +86.3% | -22.7% | +49.9% | -50.9% | +2.0% | -37.9% | +379.1% | |
| – | +12,264.7% | -42.6% | -58.8% | +706.7% | -60.5% | – | -1,016.7% | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +32.0% | +486.4% | -117.8% | -45.5% | +82.9% | +44.6% | +7.0% | -10.4% | |
| – | -24.7% | +486.4% | +4,119.8% | +1.3% | -39.7% | +109.4% | -99.3% | -105.3% | |
| – | +162,439.8% | -160.9% | – | -37.4% | -58.4% | +406.4% | -301.5% | – | |
| – | – | -142.6% | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.